Cargando…

Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis

BACKGROUND: One of the challenges facing the tuberculosis (TB) control programmes in resource-limited settings is lack of rapid techniques for detection of drug resistant TB, particularly multi drug resistant tuberculosis (MDR TB). Results obtained with the conventional indirect susceptibility testi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bwanga, Freddie, Hoffner, Sven, Haile, Melles, Joloba, Moses L
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2696456/ https://www.ncbi.nlm.nih.gov/pubmed/19457256 http://dx.doi.org/10.1186/1471-2334-9-67

Ejemplares similares

Direct Nitrate Reductase Assay versus Microscopic Observation Drug Susceptibility Test for Rapid Detection of MDR-TB in Uganda
por: Bwanga, Freddie, et al.
Publicado: (2011)

Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis
por: Walusimbi, Simon, et al.
Publicado: (2013)

Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study
por: Walusimbi, Simon, et al.
Publicado: (2016)

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda
por: Albert, Heidi, et al.
Publicado: (2010)

Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda
por: Bazira, Joel, et al.
Publicado: (2011)

Use of the GenoType(® )MTBDRplus assay to assess drug resistance of Mycobacterium tuberculosis isolates from patients in rural Uganda
por: Bazira, Joel, et al.
Publicado: (2010)

Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda
por: Walusimbi, Simon, et al.
Publicado: (2016)

Evaluation of Xpert(®) MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda
por: Katamba, Achilles, et al.
Publicado: (2023)

Antimicrobial resistance in hospitalized surgical patients: a silently emerging public health concern in Uganda
por: Seni, Jeremiah, et al.
Publicado: (2013)

Mycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban Kampala, Uganda
por: Asiimwe, Benon B, et al.
Publicado: (2008)

Quality of Sputum Specimen Samples Submitted for Culture and Drug Susceptibility Testing at the National Tuberculosis Reference Laboratory-Uganda, July-October 2013
por: Bulage, Lilian, et al.
Publicado: (2015)

Aetiology of Pulmonary Symptoms in HIV-Infected Smear Negative Recurrent PTB Suspects in Kampala, Uganda: A Cross-Sectional Study
por: Okwera, Alphonse, et al.
Publicado: (2013)

First Evaluation after Implementation of a Quality Control System for the Second Line Drug Susceptibility Testing of Mycobacterium tuberculosis Joint Efforts in Low and High Incidence Countries
por: Hillemann, Doris, et al.
Publicado: (2013)

Extensively Drug-Resistant Tuberculosis, Pakistan
por: Hasan, Rumina, et al.
Publicado: (2010)

Agreement of Middle brook 7H10 with Lowenstein Jensen and accuracy of the Sensititre MYCOTB plate using either method as a reference standard for Mycobacterium tuberculosis first line drug susceptibility testing
por: Ssengooba, Willy, et al.
Publicado: (2018)

Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment
por: Hu, Yi, et al.
Publicado: (2016)

Helicobacter pylori from Peptic Ulcer Patients in Uganda Is Highly Resistant to Clarithromycin and Fluoroquinolones: Results of the GenoType HelicoDR Test Directly Applied on Stool
por: Angol, Denish Calmax, et al.
Publicado: (2017)

Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis
por: Lukoye, Deus, et al.
Publicado: (2015)

Essential Oils from Ugandan Aromatic Medicinal Plants: Chemical Composition and Growth Inhibitory Effects on Oral Pathogens
por: Ocheng, Francis, et al.
Publicado: (2015)

Essential Oils from Ugandan Medicinal Plants: In Vitro Cytotoxicity and Effects on IL-1β-Induced Proinflammatory Mediators by Human Gingival Fibroblasts
por: Ocheng, Francis, et al.
Publicado: (2016)

Molecular Characterization of Staphylococcus aureus from Patients with Surgical Site Infections at Mulago Hospital in Kampala, Uganda
por: Seni, Jeremiah, et al.
Publicado: (2013)

Disinfectant-susceptibility of multi-drug-resistant Mycobacterium tuberculosis isolated in Japan
por: Shinoda, Noriko, et al.
Publicado: (2016)

Prevalence and Genotypic Characterization of Extended-Spectrum Beta-Lactamases Produced by Gram Negative Bacilli at a Tertiary Care Hospital in Rural South Western Uganda
por: Moses, Acaku, et al.
Publicado: (2014)

Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families
por: Kasule, George W., et al.
Publicado: (2016)

Drug Resistant Mycobacterium tuberculosis of the Beijing Genotype Does Not Spread in Sweden
por: Ghebremichael, Solomon, et al.
Publicado: (2010)

Validation of microscopic observation drug susceptibility testing for rapid, direct rifampicin and isoniazid drug susceptibility testing in patients receiving tuberculosis treatment
por: Coronel, J, et al.
Publicado: (2014)

The Mycobacterium tuberculosisUganda II family and resistance to first-line anti-tuberculosis drugs in Uganda
por: Ezati, Nicholas, et al.
Publicado: (2014)

Effect of suppressive acyclovir administered to HSV-2 positive mothers from week 28 to 36 weeks of pregnancy on adverse obstetric outcomes: a double-blind randomised placebo-controlled trial
por: Nakubulwa, Sarah, et al.
Publicado: (2017)

Higher blood volumes improve the sensitivity of direct PCR diagnosis of blood stream tuberculosis among HIV-positive patients: an observation study
por: Bwanga, Freddie, et al.
Publicado: (2015)

Use of Drug-Susceptibility Testing for Management of Drug-Resistant Tuberculosis, Thailand, 2004–2008
por: Lam, Eugene, et al.
Publicado: (2014)

Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
por: Skrahina, Alena, et al.
Publicado: (2012)

Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2016)

Genotyping and drug susceptibility testing of Mycobacterium tuberculosis in Iran: a multi-centre study
por: Mousavi, S.M.J., et al.
Publicado: (2020)

Low-cost diagnostic test for susceptible and drug-resistant tuberculosis in rural Malawi
por: Zhang, Annie, et al.
Publicado: (2018)

Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year’s review
por: Mujuni, Dennis, et al.
Publicado: (2022)

Household antimicrobial self-medication: a systematic review and meta-analysis of the burden, risk factors and outcomes in developing countries
por: Ocan, Moses, et al.
Publicado: (2015)

Dynamics of Extensive Drug Resistance Evolution of Mycobacterium tuberculosis in a Single Patient During 9 Years of Disease and Treatment
por: Hjort, Karin, et al.
Publicado: (2020)

Rates of Anti-Tuberculosis Drug Resistance in Kampala-Uganda Are Low and Not Associated with HIV Infection
por: Lukoye, Deus, et al.
Publicado: (2011)

Accuracy of GenoQuick MTB test in detection of Mycobacterium tuberculosis in sputum from TB presumptive patients in Uganda
por: Kaswabuli, Sylvia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bn5okjc5gkqln4prfo0l3jh47m